Capricor Therapeutics reported $-3932000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Cytokinetics CYTK:US $ -89.44M 58.88M
Cytori Therapeutics CYTX:US $ -4.12M 0.04M
Geron GERN:US $ -30.1M 1.92M
Newlink Genetics NLNK:US $ -7.72M 2.08M
Prothena PRTA:US $ -36.29M 3.11M
Vital Therapies VTL:US $ -20.81M 0.38M